
Opinion|Videos|November 19, 2025
Enhancing Support and Care Coordination in mCRC
Panelists discuss how support networks and coordinated care are essential for delivering third-line metastatic colorectal cancer therapies effectively in the community.
Advertisement
Episodes in this series

Panelists stress the importance of support structures, including guidance from academic institutions, professional networks, and patient advocacy groups, in expanding access to third-line therapies.
They note that effective coordination among oncologists, pharmacists, and other providers is vital to ensure safe and seamless care transitions for patients.
This collaborative approach helps optimize patient outcomes while reducing barriers to therapy initiation and adherence.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Upcoming 2026 FDA Decisions Could Expand Treatment Options Across Oncology and Hepatitis B
2
Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues
3
Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies
4
FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma
5





